Antacid effects

Racz I, Antal I, Plachy J. Formulation of controlled release drug preparations with antacid effect. Pharmazie 1996 51(May) 323— 327. 

Antacids Antacids are simple physical agents that react with protons in the lumen of the gut. Some antacids (aluminum-containing antacids) may also stimulate the protective functions of the gastric mucosa. The antacids effectively reduce the recurrence rate of peptic ulcers when used regularly in the large doses needed to significantly raise the stomach pH. 

Abstract. Crystalline and amorphous interfaces were formed and modified in multiphase composite and pharmaceutical systems. Nanosize drug of antacid effect was prepared in continuous extrusion process. The structural features were analyzed using (micro-) thermal analytical and (micro-) Raman spectrometric methods combined with chemometric evaluation. 

Magnesium oxide is an effective nonsystemic antacid, ie, it is converted to the hydroxide. It does not neutralize gastric acid excessively nor does it hberate carbon dioxide. The light form is preferable to the heavy for adininistration in Hquids because it is suspended more readily. One gram of magnesium oxide neutralizes 87 mL of 0.1 NUCl in 10 min, and 305 mL in 2 h. 

Use of the macrolides increases serum levels of digoxin and increases the effects of anticoagulants. Use of antacids decreases the absorption of most macrolides. The macrolides should not be administered with clindamycin, lincomycin, or chloramphenicol a decrease in the therapeutic activity of the macrolides can occur. Concurrent administration of the macrolides with theophylline may increase serum theophylline levels. 

Concurrent use of the fluoroquinolones with theophylline causes an increase in serum theophylline levels. When used concurrently with cimetidine, the cimetidine may interfere with the elimination of the fluoroquinolones. Use of the fluoroquinolones with an oral anticoagulant may cause an increase in the effects of the oral coagulant. Administration of the fluoroquinolones with antacids, iron salts, or zinc will decrease absorption of the fluoroquinolones. There is a risk of seizures if fluoroquinolones are given with the NSAIDs. There is a risk of severe cardiac arrhythmias when the fluoroquinolones gatifloxacin and moxifloxacin are administered with drains that increase the QT interval (eg, quini-dine, procainamide, amiodarone, and sotalol). 

Food containing salicylate (curry powder, paprika, licorice, prunes, raisins, and tea) may increase the risk of adverse reactions. Coadministration of the salicylates with activated charcoal decreases the absorption of the salicylates. Antacids may decrease the effects of the salicylates. Coadministration with the carbonic anhydrase inhibitors increases the risk of salicylism. Aspirin may increase the risk of bleeding during... 

There is an increased risk of toxicity of MTX when administered with the NSAIDs, salicylates, oral antidiabetic drugs, phenytoin, tetracycline, and probenecid. There is an additive bone marrow depressant effect when administered with other drug known to depress the bone marrow or with radiation therapy. There is an increased risk for nephrotoxicity when MTX is administered with other drug that cause nephrotoxicity. When penicillamine is administered with digoxin, decreased blood levels of digoxin may occur. There is a decreased absorption of penicillamine when the dmg is administered with food, iron preparations, and antacids. 

The antiemetics and antivertigo drug may have additive effects when used with alcohol and other CNS depressants such as sedatives, hypnotics, antianxiety drugp, opiates, and antidepressants. There may be additive anticholinergic effects (see Chap. 25) when administered with drag s that have anticholinergic activity such as the antihistamines, antidepressants, pheno-thiazines, and disopyramide The antacids decrease absorption of the antiemetics. 

The hypotensive effects of most antihypertensive dru are increased when administered with diuretics and other antihypertensives. Many dnigp can interact with the antihypertensive drugs and decrease their effectiveness (eg, antidepressants, monoamine oxidase inhibitors, antihistamines, and sympathomimetic bronchodilators). When the ACE inhibitors are administered with the NSAIDs, their antihypertensive effect may be decreased. Absorption of the ACE inhibitors may be decreased when administered with the antacids. Administration of potassium-sparing diuretics or potassium supplements concurrently with the ACE inhibitors may cause hyperkalemia. When the angiotensin II receptor agonists are administered with... 

The absorption of oral iron is decreased when tlie agent is administered with antacids, tetracyclines, penicillamine, and the fluoroquinolones. When iron is administered with levothyroxine, there may be a decrease in tlie effectiveness of levothyroxine When administered orally, iron deceases the absoqition of lev-odopa. Ascorbic acid increases tlie absoqition of oral iron. Iron dextran administered concurrently with chloramphenicol increases serum iron levels. 

The magnesium- and sodium-containing antacids may have a laxative effect and produce diarrhea Ahiminum-and calcium-containing products tend to produce constipation. Some of the less common but more serious adverse reactions include ... 

The following drugp have a decreased pharmacologic effect when administered with an antacid corticosteroids, digoxin, chlorpromazine, oral iron products, isoniazid, phenothiazines, ranitidine, phenytoin, valproic acid, and the tetracyclines. 

Calcium carbonate or magnesium hydroxide antacids may decrease the effectiveness of the digestive enzymes. When administered concurrently with an iron preparation, the digestive enzymes decrease the absorption of oral iron preparations. 

Magnesium-containing products may produce a laxative effect and may cause diarrhea aluminum- or calcium-containing antacids may cause constipation magnesium-containing antacids are used to avoid bowel dysfunction. 

Figure 9. Stabilizing effect of methylcellulose on foams generated by a suspension of effervescent antacid granules containing magnesium trisilicate and aluminum hydroxide...

Figure 9 illustrates the stabilizing effect of methylcellulose on the foams generated by a suspension of effervescent antacid granules containing magnesium trisilicate and ammonium hydroxide. Samples 1 and 2 are identical, except for 0.01% of methylcellulose contained in sample 1. The foam in sample 1 (methylcellulose) is stable even after 5 minutes, while the sample without methylcellulose has virtually no foam after 30 seconds. 

Lambrecht, N., Korolkiewicz, R and Peskar, B.M. (1992). Effects of endo nous nitric oxide (NO) inhibition on the gas-troprotective activity of the antacid hydrotalcit in rats. Gas-troenterolcgy 102, A105. 

---